Not applicableUnknownNCT04510714What this trial is testingBORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]Who this might be right forSarcoma Instituto do Cancer do Estado de São Paulo 60
Testing effectiveness (Phase 2)Study completedNCT00626704What this trial is testingPhase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaWho this might be right forLocally Advanced or Metastatic, Unresectable Soft Tissue SarcomaSarcomaSoft Tissue Sarcoma Amgen 134
Testing effectiveness (Phase 2)UnknownNCT00033709What this trial is testingTemozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaWho this might be right forSarcoma Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00289809What this trial is testingTLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma PatientsWho this might be right forSarcoma, Soft Tissue Istituto Clinico Humanitas 36
Not applicableStudy completedNCT01062438What this trial is testingStudying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic OsteosarcomaWho this might be right forSarcoma Children's Oncology Group 99
Large-scale testing (Phase 3)Study completedNCT00987636What this trial is testingStudy in Localized and Disseminated Ewing SarcomaWho this might be right forEwing's Sarcoma University Hospital Muenster 907
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358
Testing effectiveness (Phase 2)UnknownNCT05138146What this trial is testingClinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT04273061What this trial is testingInvestigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityWho this might be right forBreast CancerLung CancerGastrointestinal Cancer+6 more British Columbia Cancer Agency 50
Not applicableStudy completedNCT00335751What this trial is testingPET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue SarcomaWho this might be right forSarcoma Jonsson Comprehensive Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT04216953What this trial is testingMEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue SarcomaWho this might be right forSarcoma,Soft Tissue Centre Leon Berard 229
Not applicableActive Not RecruitingNCT03737734What this trial is testingAlpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Who this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 30
Testing effectiveness (Phase 2)Study completedNCT04873375What this trial is testingCemiplimab for Secondary AngiosarcomasWho this might be right forSecondary AngiosarcomaLocally Advanced SarcomaMetastasis Radboud University Medical Center 18
Early research (Phase 1)Ended earlyNCT05605522What this trial is testing[225Ac]-FPI-2059 in Adult Participants With Solid TumoursWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC)Squamous Cell Carcinoma of Head and NeckColorectal Cancer+4 more 3B Pharmaceuticals GmbH 19
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04332874What this trial is testingPembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegWho this might be right forSarcomaMyxofibrosarcomaUndifferentiated Pleomorphic Sarcoma+1 more Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT05580588What this trial is testingOpen-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic LiposarcomasWho this might be right forLiposarcoma, Dedifferentiated Shanghai Pharma Biotherapeutics USA Inc. 14
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)UnknownNCT03416517What this trial is testingAnlotinib and Irinotecan for Ewing SarcomaWho this might be right forEwing's Tumor Metastatic Peking University People's Hospital 47
Testing effectiveness (Phase 2)Study completedNCT00659360What this trial is testingAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaWho this might be right forAdult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more National Cancer Institute (NCI) 17